These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thermal stabilities of hemoglobins crosslinked with different length reagents. Huang H; Olsen KW Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):719-24. PubMed ID: 7994393 [TBL] [Abstract][Full Text] [Related]
3. Large scale preparation of functional human placental hemoglobin for use in blood substitutes. Fasan G; Vigneron C; Dellacherie E; Grandgeorge M Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):489-91. PubMed ID: 1391468 [No Abstract] [Full Text] [Related]
4. Pilot scale production of pyrogen-free human hemoglobin for research. Chapman KW; Snell SM; Jesse RG; Morano JK; Everse J; Winslow RM Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):415-21. PubMed ID: 1391457 [TBL] [Abstract][Full Text] [Related]
5. Endotoxin removed from hemoglobin solution using polymyxin-B immobilized fibre (PMX-F) followed by a new turbidometric endotoxin assay. Tani T; Chang TM; Kodama M; Tsuchiya M Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):457-62. PubMed ID: 1391464 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies. Nelson D; Azari M; Brown R; Burhop K; Bush S; Catarello J; Chuang H; Downing C; Estep T; Loewen A Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):423-7. PubMed ID: 1391458 [TBL] [Abstract][Full Text] [Related]
12. Enzymatic protection from autoxidation for crosslinked hemoglobins. Yang T; Olsen KW Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):709-17. PubMed ID: 7994392 [TBL] [Abstract][Full Text] [Related]
13. A convenient method for the determination of the solubility of hemoglobin and modified hemoglobins. Anderson PJ; Biro GP Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):753-61. PubMed ID: 7994398 [TBL] [Abstract][Full Text] [Related]
14. Bissulfosuccinimidyl esters of aliphatic dicarboxylic acids: a new class of 'affinity directed' beta beta crosslinkers of HbA. Manjula BN; Roy RP; Smith PK; Acharya AS Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):747-52. PubMed ID: 7994397 [TBL] [Abstract][Full Text] [Related]
15. Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: an overview. Chang TM Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):159-79. PubMed ID: 1391433 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of crosslinked and polymerized hemoglobin solutions. Bakker JC; Berbers GA; Bleeker WK; den Boer PJ; Biessels PT Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):233-41. PubMed ID: 1391437 [TBL] [Abstract][Full Text] [Related]
19. Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin. Farmer M; Ebeling A; Marshall T; Hauck W; Sun CS; White E; Long Z Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):429-33. PubMed ID: 1327242 [TBL] [Abstract][Full Text] [Related]
20. Possible importance of chromatographic purification position in a blood substitute elaboration process. Menu P; Faivre B; Labrude P; Grandgeorge M; Vigneron C Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):443-5. PubMed ID: 1391461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]